title: [Treatment of female urinary incontinence].
authors.affiliation: Beckenbodenzentrum Klinikum der Universität München-Grosshadern, Ludwig-Maximilians-Universität. Ricarda.Bauer@med.uni-muenchen.de
authors.forename: R M
authors.initials: RM
authors.lastname: Bauer
authors.forename: C
authors.initials: C
authors.lastname: Gozzi
authors.forename: M
authors.initials: M
authors.lastname: Mayer
authors.forename: C
authors.initials: C
authors.lastname: Gratzke
authors.forename: I
authors.initials: I
authors.lastname: Soljanik
authors.forename: P J
authors.initials: PJ
authors.lastname: Bastian
authors.forename: C G
authors.initials: CG
authors.lastname: Stief
authors.forename: C
authors.initials: C
authors.lastname: Dannecker
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D000068736:Duloxetine Hydrochloride; D005260:Female; D006801:Humans; D008019:Life Style; D012307:Risk Factors; D053825:Suburethral Slings; D013876:Thiophenes / Q000627:therapeutic use; D016896:Treatment Outcome; D014549:Urinary Incontinence / Q000145:classification / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D018680:Cholinergic Antagonists; D013876:Thiophenes; D000068736:Duloxetine Hydrochloride; D019274:Botulinum Toxins, Type A